| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |